Maternal and Child Health Practice Questions

Q: When prescribing oral contraceptive pills, which of the following should a female health worker evaluate, EXCEPT?

Having two live issues. The primary objective when screening a patient for Combined Oral Contraceptive Pills (COCPs) is to identify **medical contraindications** that could lead to life-threatening complications, rather than assessing their parity or family size. ### Why "Having two live issues" is the Correct Answer The number of children a woman has (parity) is a social or demographic factor, not a medical contraindication. While family planning counseling may change based on the number of children, it does not affect the **safety profile** of the pill. A woman can safely take COCPs regardless of whether she has zero, two, or five children, provided she has no medical risks. ### Evaluation of Incorrect Options (Medical Contraindications) * **Calf Tenderness:** This is a clinical sign of **Deep Vein Thrombosis (DVT)**. Estrogen in COCPs increases the synthesis of clotting factors, significantly raising the risk of thromboembolism. Any history or sign of venous thrombosis is an absolute contraindication. * **Convulsions:** Patients with a history of epilepsy require careful evaluation because many **anti-epileptic drugs (AEDs)** like Phenytoin or Carbamazepine are hepatic enzyme inducers. They increase the metabolism of OCPs, leading to contraceptive failure. * **History of Chronic Headache:** Specifically, **Migraine with aura** is a major contraindication due to a significantly increased risk of ischemic stroke when combined with estrogen-containing pills. ### High-Yield Clinical Pearls for NEET-PG * **WHO Eligibility Criteria Category 4 (Absolute Contraindications):** Smokers >35 years (>15 cigarettes/day), history of DVT/PE, Migraine with aura, Breast cancer, and undiagnosed abnormal uterine bleeding. * **Non-contraceptive benefits:** COCPs reduce the risk of Ovarian and Endometrial cancers (protective effect lasts for years after discontinuation). * **Drug Interaction:** Rifampicin is the most potent enzyme inducer that decreases OCP efficacy.

Q: Cu 380A should be replaced once in how many years?

10 years. **Explanation:** The **Copper T 380A (Cu 380A)** is a second-generation Intrauterine Contraceptive Device (IUCD) and is currently the most widely used copper IUD worldwide. The "380" refers to the surface area of copper (380 $mm^2$) wrapped around the polyethylene frame. **Why 10 years is correct:** The Cu 380A is FDA-approved and recommended by the Government of India (under the National Family Planning Program) for a duration of **10 years**. The high surface area of copper ensures a slow, steady release of copper ions, which are spermicidal and prevent fertilization. While some studies suggest it may remain effective for up to 12 years, for exam purposes and clinical guidelines, the replacement interval is strictly 10 years. **Why other options are incorrect:** * **4 and 6 years:** These durations do not correspond to any standard copper IUD. Older models like the Lippes Loop were permanent until menopause, but modern copper devices have specific lifespans. * **8 years:** While longer than some devices, it is not the standardized duration for the 380A model. Note that the **Cu T 375** (Multiload) is replaced every **5 years**. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Primarily **pre-fertilization** (spermicidal); it causes a sterile inflammatory response in the endometrium. * **Ideal Candidate:** Monogamous parous women (low risk of PID). * **Ideal Time of Insertion:** Within 10 days of the menstrual cycle (to ensure the patient is not pregnant). * **Post-partum Insertion:** Can be inserted within 48 hours (PPIUCD) or after 6 weeks (involution complete). * **Emergency Contraception:** Cu 380A is the **most effective** method of emergency contraception if inserted within 5 days of unprotected intercourse.

Q: Which one of the following is categorized as a high-risk pregnancy?

Twin pregnancy. **Explanation:** In Community Medicine and Obstetrics, a **High-Risk Pregnancy** is defined as one where the mother or fetus has a significantly increased risk of morbidity or mortality compared to a normal pregnancy. **1. Why Twin Pregnancy is correct:** Multiple gestations (like twins) are inherently high-risk because they significantly increase the likelihood of complications for both the mother and the fetuses. Maternal risks include pre-eclampsia, gestational diabetes, and postpartum hemorrhage. Fetal risks include preterm labor, intrauterine growth restriction (IUGR), and malpresentation. **2. Analysis of Incorrect Options:** * **Birth order 3:** According to the WHO and standard obstetric guidelines, high-risk birth orders are the **first pregnancy (primigravida)** and **grand multipara (5th pregnancy onwards)**. Birth orders 2, 3, and 4 are generally considered low-risk. * **Maternal height 150 cm:** A mother is categorized as "short-statured" and high-risk if her height is **less than 145 cm** (4'9"). This is a risk factor for Cephalopelvic Disproportion (CPD). 150 cm is above this threshold. * **Blood group AB positive:** This is a normal finding. High-risk blood groups involve **Rh-negative** status (due to the risk of isoimmunization) or severe anemia (Hb 35 years is high-risk. * **Weight criteria:** Pre-pregnancy weight 70 kg. * **Interval:** An inter-pregnancy interval of less than 2 years. * **Medical conditions:** Presence of Hypertension, Diabetes, Heart Disease, or previous C-section are all high-risk markers.

Q: In a population of 4000 people, the crude birth rate is 10 per 1000 population. Calculate the number of pregnant females.

44. ### Explanation To calculate the number of pregnant females in a population, we must first determine the number of live births and then account for pregnancy wastage (abortions and stillbirths). **1. Calculate the number of Live Births:** The Crude Birth Rate (CBR) is defined as the number of live births per 1000 population per year. * Formula: $\text{Total Live Births} = \frac{\text{CBR} \times \text{Total Population}}{1000}$ * Calculation: $\frac{10 \times 4000}{1000} = 40$ live births. **2. Account for Pregnancy Wastage:** In Community Medicine, it is a standard convention to add **10%** to the number of live births to account for pregnancies that do not result in a live birth (miscarriages, stillbirths, etc.). * Pregnancy Wastage = $10\% \text{ of } 40 = 4$. * Total Pregnant Females = $40 (\text{Live Births}) + 4 (\text{Wastage}) = \mathbf{44}$. --- ### Analysis of Options: * **A (40):** This represents only the number of live births. It is incorrect because it fails to account for the total pool of pregnant women, including those whose pregnancies may not reach term. * **B (44):** **Correct.** This includes the 40 live births plus the 10% correction factor for pregnancy wastage. * **C & D (54 & 70):** These values are mathematically inconsistent with the provided CBR and population size. --- ### High-Yield Clinical Pearls for NEET-PG: * **Standard Correction Factor:** Always add 10% to the number of live births to estimate the total number of pregnancies in a community for health planning (e.g., calculating ANC registration needs). * **Eligible Couples:** In a general Indian population, there are approximately 150–180 eligible couples per 1000 population. * **Net Reproduction Rate (NRR):** The target for the National Health Policy is to achieve NRR = 1 (replacement level fertility), which roughly corresponds to a Total Fertility Rate (TFR) of 2.1.

Q: The Baby-Friendly Hospital Initiative (BFHI) recommends which of the following practices?

Rooming-in. The **Baby-Friendly Hospital Initiative (BFHI)**, launched by WHO and UNICEF in 1991, is based on the **"Ten Steps to Successful Breastfeeding."** ### **Why "Rooming-in" is Correct** **Step 7** of the BFHI guidelines specifically mandates **Rooming-in**, which allows mothers and infants to remain together 24 hours a day. This practice is crucial because it facilitates demand feeding, strengthens maternal-infant bonding, and increases the success rate and duration of exclusive breastfeeding. ### **Analysis of Incorrect Options** * **A. An oral breastfeeding policy:** This is incorrect because **Step 1** requires a **written** breastfeeding policy that is routinely communicated to all healthcare staff. * **C. Four-hourly breastfeeding:** This is incorrect because **Step 8** encourages **breastfeeding on demand** (whenever the baby shows hunger cues), rather than following a rigid schedule. * **D. Breastfeeding within one hour of birth:** While this is a core recommendation of BFHI (**Step 4**), the standard guideline specifies initiating breastfeeding within **30 minutes** of birth (especially for vaginal deliveries). In many recent exams, "Rooming-in" is the more classically tested "Step" among these options. ### **High-Yield Clinical Pearls for NEET-PG** * **The 10th Step:** Refers to fostering the establishment of breastfeeding support groups and referring mothers to them on discharge. * **Step 6 (No supplements):** Give newborn infants no food or drink other than breast milk, unless medically indicated (No pre-lacteal feeds). * **Step 9 (No artificial teats):** Give no artificial teats or pacifiers (soothers) to breastfeeding infants to prevent nipple confusion. * **Recent Update:** The BFHI guidelines were updated in 2018 to emphasize "responsive feeding" and integrating the program into the broader "Quality of Care" framework.

Q: What is the minimum number of postnatal visits a female health worker should conduct in her area?

2. **Explanation:** The correct answer is **2 (Option B)**. This is based on the specific job responsibilities of a **Female Health Worker (ANM)** as defined under the National Rural Health Mission (NRHM) and RMNCH+A guidelines in India. **Why Option B is correct:** According to the operational guidelines, an ANM is mandated to conduct a minimum of **two postnatal visits** for every delivery in her area. These visits are crucial for monitoring maternal recovery, identifying postpartum complications (like PPH or sepsis), and ensuring neonatal well-being. * **1st Visit:** Within 48 hours of delivery (if the delivery was at home) or immediately after discharge (if institutional). * **2nd Visit:** On the 14th day after delivery. **Why other options are incorrect:** * **Option A (1):** A single visit is insufficient to monitor the critical six-week involution period and neonatal milestones. * **Option C (3) & D (4):** While the **total** number of postnatal contacts recommended by the WHO is 4, and the number of visits by an **ASHA** worker is higher (6 for institutional, 7 for home deliveries), the specific statutory requirement for the **Female Health Worker (ANM)** remains 2. **High-Yield Facts for NEET-PG:** * **ASHA’s Schedule:** Under the Home Based Newborn Care (HBNC) scheme, an ASHA conducts **6 visits** (Days 3, 7, 14, 21, 28, 42) for institutional deliveries and **7 visits** (Day 1 added) for home deliveries. * **WHO Recommendation:** Recommends at least **4 postnatal checkups** (within 24 hours, day 3, between days 7–14, and at 6 weeks). * **Postnatal Period:** Defined as the first 6 weeks (42 days) following delivery. * **Most Critical Period:** The first 48 hours, as the majority of maternal and neonatal deaths occur during this window.

Q: The use of aluminium in vaccines is as:

Adjuvant. **Explanation:** **1. Why Adjuvant is Correct:** Aluminium salts (such as aluminium hydroxide or aluminium phosphate) are the most commonly used **adjuvants** in human vaccines. An adjuvant is a substance added to a vaccine to **enhance and prolong the immune response** to the antigen. It works via the "depot effect," where the antigen is released slowly at the injection site, ensuring prolonged exposure to immune cells. It also recruits antigen-presenting cells (APCs) and stimulates the production of inflammatory cytokines, leading to a more robust antibody response. **2. Why Other Options are Incorrect:** * **Stabiliser:** These are used to maintain vaccine effectiveness during storage (e.g., protecting against heat or freeze-thaw cycles). Examples include gelatin, lactose, or sorbitol. * **Preservative:** These prevent the growth of bacteria or fungi in multi-dose vials. The most common example is **Thiomersal** (an ethylmercury compound). * **Antibiotic:** These are used during the manufacturing process to prevent bacterial contamination. Common examples include neomycin or polymyxin B. **3. High-Yield Clinical Pearls for NEET-PG:** * **Vaccines containing Aluminium:** DPT, DT, Tetanus Toxoid (TT), Hepatitis B, and Hepatitis A. * **Storage Note:** Vaccines containing aluminium adjuvants **must never be frozen**. Freezing causes the aluminium to precipitate, leading to a loss of potency and increased risk of local reactions (sterile abscesses). This is why they are kept in the "cold part" but not the "freezing part" of the ILR. * **Live Vaccines:** Generally, live attenuated vaccines (like BCG, OPV, or Measles) do **not** contain adjuvants.

Q: What is the haemoglobin cut-off level for determining the prevalence of anemia among pregnant women?

Less than 11 g/dL. ### Explanation **1. Why Option C is Correct:** According to the **World Health Organization (WHO)** and the **National Health Mission (NHM)** guidelines, anemia in pregnancy is defined as a hemoglobin (Hb) level of **<11 g/dL**. This threshold is lower than that for non-pregnant women (12 g/dL) due to **hemodilution**. During pregnancy, plasma volume increases significantly more (approx. 50%) than the red cell mass (approx. 20%), leading to a physiological drop in hemoglobin concentration. **2. Why Other Options are Incorrect:** * **Option A (15 g/dL):** This is within the normal range for healthy adult males and is far too high to be a cut-off for anemia. * **Option B (13 g/dL):** This is the WHO cut-off for anemia in **adult men**. * **Option D (19 g/dL):** This value suggests polycythemia (excessive RBCs) rather than anemia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Severity Classification (WHO/Anemia Mukt Bharat):** * **Mild:** 10.0 – 10.9 g/dL * **Moderate:** 7.0 – 9.9 g/dL * **Severe:** < 7.0 g/dL * **Very Severe:** < 4.0 g/dL (Medical emergency) * **Prophylaxis (IFA):** Under the *Anemia Mukt Bharat* strategy, pregnant women should receive **100 mg elemental iron and 500 mcg folic acid** daily for 180 days, starting from the second trimester (14 weeks). * **Treatment:** If diagnosed with anemia, the dose is doubled (twice daily). * **Most Common Cause:** Nutritional Iron Deficiency is the leading cause of anemia in pregnancy in India.

Question 1

The number of abortions performed divided by the number of live births in the same period is known as?

Accepted Answer

Abortion ratio

Answer

Abortion rate

Answer

Abortion incidence

Answer

Abortion prevalence

Question 2

Which is the best index for measuring contraceptive efficacy?

Accepted Answer

Life-table analysis

Answer

Pearl index

Answer

Chandler's index

Answer

Quetelet index

Question 3

When prescribing oral contraceptive pills, which of the following should a female health worker evaluate, EXCEPT?

Accepted Answer

Having two live issues

Answer

Calf tenderness

Answer

Convulsions

Answer

History of chronic headache

Question 4

Cu 380A should be replaced once in how many years?

Accepted Answer

10 years

Answer

4 years

Answer

6 years

Answer

8 years

Question 5

Which one of the following is categorized as a high-risk pregnancy?

Accepted Answer

Twin pregnancy

Answer

Birth order 3

Answer

Maternal height 150 cm

Answer

Blood group AB positive

Question 6

In a population of 4000 people, the crude birth rate is 10 per 1000 population. Calculate the number of pregnant females.

Accepted Answer

44

Answer

40

Answer

54

Answer

70

Question 7

The Baby-Friendly Hospital Initiative (BFHI) recommends which of the following practices?

Accepted Answer

Rooming-in

Answer

An oral breastfeeding policy among the staff

Answer

Four-hourly breastfeeding

Answer

Breastfeeding within one hour of birth

Question 8

What is the minimum number of postnatal visits a female health worker should conduct in her area?

Accepted Answer

2

Answer

1

Answer

3

Answer

4

Question 9

The use of aluminium in vaccines is as:

Accepted Answer

Adjuvant

Answer

Stabiliser

Answer

Preservative

Answer

Antibiotic

Question 10

What is the haemoglobin cut-off level for determining the prevalence of anemia among pregnant women?

Accepted Answer

Less than 11 g/dL

Answer

Less than 15 g/dL

Answer

Less than 13 g/dL

Answer

Less than 19 g/dL

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?